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We compared integrin-mediated adhesion to extracellular 
matrix (ECM) components of cultured human melanocytes and
6 human melanoma cell lines with different metastatic capaci­
ties in nude mice. Cultured melanocytes and most melanoma 
cell lines adhered strongly to fibronectin (FN), whereas only 
highly metastatic cell lines adhered to laminin (LM), collagen 
type I (COI) and type IV (COIV). Adhesion to LM and CO could 
be blocked by anti-a6 and anti-<x2 monoclonal antibodies (MAbs) 
respectively. This observation is consistent with the finding that 
expression of LM receptor c^ß, and LM/CO receptor a2ßi was 
low on melanocytes and non- or poorly metastatic cell lines, 
whereas these integrins were strongly expressed on highly 
metastatic cell lines. In addition, immunoprécipitation from 
[35S]-methionine-labeled cells demonstrated increased synthe­
sis of a*, a2 and ßi in highly metastatic cell lines and immunohis- 
tochemistry showed expression of o^ßi and a2ß, only in xeno­
graft lesions from highly metastatic cell lines. Furthermore, the 
observation that adhesion of melanocytes and non- or poorly 
metastatic cell lines could be stimulated with anti ßl MAbs 
demonstrates that these receptors, on these cells, are ex­
pressed in an inactive state. Our results suggest that a2ßj and 
o^ß, play a role in human melanoma metastasis in nude mice 
and demonstrate that interactions of these integrins with their 
ligands can be regulated at the level of surface expression and 
activation state of the receptor.
© 1993 Wiley-Liss, Inc.
Crucial steps in the process of metastasis are the release and 
migration of cells from the primary tumor, penetration of the 
vessel wall, arrest in the microcirculation of distant organs and 
subsequent extravasation (Poste and Fidler, 1980). During this 
process the malignant cells interact several times with the 
ECM components of basal lamina and stroma including LM, 
CO and FN through specific receptors on the cell membrane. 
Interaction between cells and ECM components is mainly 
mediated by integrins.
Integrins consist of a superfamily of transmembrane recep­
tors. Structurally, each integrin is a heterodimer consisting of 
an a subunit non-covalently bound to a ß subunit. Based on the 
type of ß subunit present in the dimer, the integrin superfamily 
can be subdivided into several families (Hynes, 1992), The 
most extensively studied are the ßi, ß2 and ß3 families. Beta-1 
integrins (very late antigens, VLAs) play an important role in 
mediating cell-ECM contacts; ß2 integrins are exclusively 
expressed on leukocytes and mediate cell-cell contacts, whereas 
ß3 integrins have a broader distribution and mediate cell- 
ECM interactions. In order to mediate their functions, inte­
grins have to be in an activated state. For ßi integrins, this has 
been shown by Shimizu et al (1990),
Integrin expression and adhesive behavior of cells can 
change after transformation. F2408 rat fibroblast and normal 
rat kidney (NRK) cells show reduced adhesion to FN after 
viral transformation (Plantefaber and Hynes, 1989) and cer­
tain human osteosarcoma cells show a changed pattern of 
integrin expression and of adhesive properties after further
chemical transformation (D edhar and Saulnier, 1990). Further­
more, transfection of the a2 gene has demonstrated the 
importance of VLA-2 in the metastatic process of rat rhabdo­
myosarcoma cells (Chan et a l , 1991), while transfection of the 
av gene in M21 human melanoma cells that lack VNR 
expression has restored their tumorigenicity (Felding-Haber- 
mann et a l3 1992). Finally, VLA-2 (Bröcker et a l, 1985; Klein 
et al, 1991), and the ß3 subunit (Alb eld a et ai, 1990), have 
been shown to be preferentially expressed in vertical-growth- 
phase primary melanoma lesions and melanoma métastasés, 
suggesting a role in melanoma progression.
The purpose of this study is to investigate whether a 
correlation exists between the metastatic potential of human 
melanoma cell lines in nude mice and their capacity to adhere 
to ECM components in vitro, which integrins are involved and 
what the activation state of the integrins is on the various cell 
types.
MATERIAL AND METHODS 
Cell lines and culture conditions
The melanoma cell lines used included: IF 6 (Van Muijen et 
al, 1991«), 530 (Versteeg et a l, 1988), M14 (Katano et al, 
1984), Mel57 (Brüggen et a l, 1978), BLM  (Van Muijen et al, 
1991 a) and MV3 (Van Muijen et al, 1991 b). All cell lines were 
cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
(Flow, Irvine, UK) supplemented with 10% FCS, gentamycin, 
glutamate and pyruvate. Isolation and propagation of human 
foreskin melanocytes were performed as described by Smit et 
al (1989) and melanocytes were cultured for a maximum of 10 
passages in Ham ’s F10 (Flow) supplemented with 2% Ultro- 
ser-G synthetic serum (GIBCO, Grand Island NY) glutamate, 
penicillin, streptomycin, 0.1 mM IBM X  (Sigma, St Louis MO) 
and 16 nM phorbol 12-myristate 13-acetate (PMA) (Sigma).
Monoclonal antibodies
The following anti-integrin subunit MAbs were used. TS2/7 
anti at (Hemler et a l, 1984) (T-cell Sciences, Cambridge MA); 
A1.43 anti a2 (Bröcker et al, 1985; Klein et al, 1991) (Cell 
Diagnostica, Münster, Germany); 5E8 anti-ct2 (Zylstra et al, 
1986); J143 anti-ot3 (Fradet et al, 1984); GoH3 anti a 6 
(Sonnenberg et al, 1987); 4B4 anti-ßi (Morimoto et al, 1985) 
(Coulter, Hialeah, FL); 8A2 anti-ßi (Kovach et al, 1992); 
TS2/16 anti~ßi (Hemler et al, 1984); 3E1 anti-ß4 (Hessle et al, 
1984) (Telios, San Diego, CA). As negative controls in the 
FACS experiments, WT31 anti-CD3 (Spits et a l, 1985; Taxer 
al, 1983) MAbs were used. As negative controls in the 
adhésion-inhibition assays, W 6/32 anti-M HC class-I (Barnsta-
3To whom correspondence and reprint requests should be ad­
dressed, at the Department of Pathology, University Hospital Nijme­
gen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Fax: 
31-80-540520.
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ble et al, 1978) MAbs were used. M H C  class I is strongly 
expressed on all cell lines (Van Muijen et al, 1991^) and on 
cultured melanocytes (not shown).
FACS analysis
Cells were harvested by short trypsinization of subconfluent 
monolayers. A fter washing with D M E M  containing 10% FCS, 
they were incubated with MAbs in PBS containing 0.5% BSA 
and 0.02% azide for 30 min at 0°C. After 3 washes with 
PBS/BSA/azide, the cells were incubated with fluorescein- 
isothiocyanate (FITC)-conjugated F (a b ')2 fragments of rabbit 
anti-(mouse Ig) antibodies (Dako, Glostrup, Denmark) or, in 
the case of GoH3 MAbs, with FITC-conjugated rabbit anti­
mat Ig) antibodies (Dako). Analyses were performed on an 
Epics Elite (Coulter, Mijdrecht, The Netherlands).
Immunoprécipitations
Subconfluent monolayer cell cultures (75 cm2) were labeled 
overnight at 37°C with 0.3 mCi [35S]-methionine (Amersham, 
Houten, The Netherlands) in methionine-free medium (Flow) 
containing 10% dialysed FCS. The cells were washed twice 
with PBS and incubated with NP40 lysis buffer (0.5% NP40, 
0.015 M NaCI, 0.01 M Tris pH  7.5, 1.0 mM phenyl-methyl- 
sulphonyl-fluoride and 4 p-g/ml Aprotinin) at 4°C for 10 min. 
Subsequently, the cells were scraped out of the culture flask, 
repeatedly aspirated into syringes and forced through needles 
of decreasing diameters. Glycoproteins were isolated from 
NP40 solubilized cell extracts by adsorption to concanavalin A  
(Con A) Sepharose (Pharmacia, Uppsala, Sweden). Immuno­
précipitations were performed as described by Klein (1988); 
To compare the amount of glycoproteins in the various cell 
lines, equal numbers of counts of the Con-A-bound fractions 
were used for immunoprécipitation.
1mm unohisto ch em is fry
After acetone fixation, 4-jxm frozen sections were incubated 
with MAbs for 1 hr at room tem perature. After washing with 
PBS, bound MAbs were visualized using peroxidase-conju- 
gated rabbit anti-(mouse Ig) or (in the case of GoH3 MAbs) 
with goat anti-(rat Ig) antibodies (Dako) and amino-ethyl 
carbazol (AEC). After counterstaining with Harris hematoxy­
lin the sections were mounted with Kaizer’s glycerin/gelatin.
Cell adhesion assays
LM and COIV, both isolated from Engelbreth-Holm-Swarm 
mouse sarcoma cells, were purchased from GIBCO. COI, 
isolated from ra t tail, was a gift from Dr. E. Klein, Ulm, 
Germany. FN, isolated from human plasma, was purchased 
from Sigma. Polystyrene microtiter plates (96 flatbottomed 
wells; Greiner, Alphen a /d  Rijn, T he  Netherlands) were 
coated by incubation overnight at 4°C with 50 pJ of a solution 
containing 20 |xg/ml of the appropriate adhesive protein in 
PBS. Unbound protein was removed by washing with PBS and 
free binding sites were blocked by incubation for 1 hr at 37°C 
with D M EM  containing 0.25% BSA. Cells were harvested by 
short trypsinization of subconfluent monolayers, washed with 
DM EM  containing 0.25% BSA and labeled in a volume of 
approx. 100 [i\ with 50 |xCi N a351CrO for 90 min at 37°C. 
Subsequently, the cells were washed 3 times, diluted to a 
concentration of 1 x 105 cells/ml in D M E M  containing 0.25% 
BSA and seeded into the wells (5,000 cells/well). Cells were 
allowed to attach for 30 min at 37°C in a 5% CO2 atmosphere; 
non-adherent cells were removed by washing 3 times with 
DM EM  containing 0.25% BSA; the attached cells were lysed 
with Triton-X-100 and radioactivity was measured in a gamma- 
counter. In adhesion inhibition/stimulation assays cells were 
incubated with the appropriate MAbs for 30 min at 4°C before 
seeding into the wells.
RESULTS
Metastatic behavior o f human melanoma cell lines in nude mice
The rate of tumor take and the frequency of experimental 
and spontaneous metastasis of the human melanoma cell lines 
studied in nude mice has been described (Van Muijen et al, 
1991a,b). Although, after sx. inoculation, all cell lines gave a 
good tumor take, only BLM and MV3 were highly metastatic. 
IF6 and 530 did not metastasize at all and M14 and Mel57 
were only poorly metastatic.
Adhesion to ECM components
To investigate whether the capacity to metastasize was 
reflected by the capacity to adhere to ECM  components, we 
investigated adhesion to LM, COI, COIV and FN. Melano­
cytes, and the non-metastatic (1F6, 530) and poorly metastatic 
cells (M14, Mel57) adhered weakly to LM, COI and COIV 
whereas the highly metastatic BLM and MV3 melanoma cells 
adhered strongly to these ECM  components (Fig. 1). A 
different pattern was found for adhesion to FN. Most cells 
exhibited strong binding to FN and only 530 cells adhered 
weakly to FN, These results indicate that highly metastatic 
melanoma cells adhere to LM and CO more strongly than non- 
or poorly metastatic cells.
Expression o f LM  ICO receptors
As adhesion to LM and CO was strongly increased in highly 
metastatic cell lines, surface expression of integrins, known to 
mediate adhesion to LM (<*ißi, a 2ßi, a 3ßi, a 6ßi, a 6ß4) or CO 
(ctißi, a 2ßi, a 3ßi) was investigated by means of FACS analysis. 
Melanocytes and all 6 cell lines expressed ß t integrins (Fig. 2). 
Expression of ßi was high on melanocytes and the highly 
metastatic BLM and MV3 cells, and low on the other cell lines. 
Expression of 04 was low, both on melanocytes and on all cell 
lines. Expression of a2 and a 6 was high on the highly metastatic 
BLM and MV3 cells, whereas melanocytes and all other cell 
lines showed only weak expression or none at all. Expression of 
the a 3 subunit was high on melanocytes and the highly 
metastatic BLM and MV3 cells, moderate on IF6 and Mel57 
and low or undetectable on 530 and M14. No ß4 expression was 
found on melanocytes or any of the cell lines, even though 
MAbs against ß4 stained control cells (keratinocytes; not 
shown). From these results it can be concluded that the 
expression of a 6ß! and a 2ßi is strongly increased on highly 
metastatic melanoma cells compared to non- or poorly meta­
static melanoma cells and normal melanocytes.
To establish whether differences in cell-surface expression 
were reflected by differences in the level of biosynthesis of 
integrin subunits, immunoprécipitation was performed on the 
glycoprotein fraction of [35S]-methionone-labeled melanoma 
cells. No ai or ß4 could be precipitated from any of the cell 
lines and a 3 synthesis was detected in all cell lines except 530 
and M14 (Fig. 3). Consistent with the surface expression data, 
the level of synthesis of ßi, a2 and a 6 was increased in the 
highly metastatic BLM and MV3 cells as compared with the 
other cell lines.
Finally, we determined whether increased expression of 
LM /CO receptors also occurred in situ. Immunohistochemis- 
try was performed on s.c. xenograft lesions from the non­
metastatic cell lines IF6 and 530 and from the highly metastatic 
cell lines BLM and MV3. Expression of a2 and was only 
detected in lesions of the highly metastatic BLM and MV3 
cells (Fig. 4), as in the case of cultured cells.
Role of a 2ßy and a S i  in adhesion to L M  and CO
To further demonstrate the role of a 2ßi and c^ß! in adhesion 
to LM, COI and COIV we performed antibody-blocking 
studies. Since adhesion of normal melanocytes and the non­
metastatic (IF6, 530) or poorly metastatic melanoma cells
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F ig u r e  1 -  Adhesion of cultured human melanocytes (MCT) and 6 human melanoma cell lines to LM, COI, COIV and FN. Control 
adhesion to BSA was less then 5%. SD of triplicate determinations did not exceed 10%, One experiment out of 4 is shown.
(M14 and MeI57) to LM, COI or COIV was absent or low (Fig. 
1), we only examined the highly metastatic BLM and MV3 
cells. Adhesion of BLM and MV3 to LM could be inhibited by 
60% by MAbs directed against a 2 (Fig, 5), and MAbs directed 
against or ßj completely blocked adhesion of these cells to 
LM. Adhesion to COI and COIV was almost completely 
inhibited by MAbs directed to «2 or ßj. These results indicate 
that o^ßi and a 6ßi are the major receptors for CO and LM, on 
highly metastatic melanoma cells.
Effect o f stimulating anti ßy MAbs on adhesion to LM  and CO
In order to determine whether differences in adhesion to 
LM and COI between cells of varying metastatic capacities 
were due not only to differences in expression of LM /CO 
receptors but also to the activation state of these receptors, we 
performed adhesion assays in the presence of 8A 2 or TS2/16 
anti-ßi MAbs. MAbs 8A2 and TS2/16 have been reported to
stimulate integrin-mediated adhesion, possibly by a conforma­
tional change of the receptors. Following incubation with these 
MAbs, normal melanocytes and non- and poorly metastatic 
melanoma cells adhered  strongly to LM  and COI (Fig. 6). No 
stimulatory effects, or only minor ones, were observed with the 
highly metastatic BLM  and MV3 ceils (not shown). From these 
results we conclude that integrin receptors for LM and CO on 
normal melanocytes and non- and poorly metastatic melanoma 
cells are expressed in an inactive state, whereas these receptors 
are constitutively active in highly metastatic melanoma cells.
DISCUSSION
During metastasis, tum or cells interact at several sites with 
the E C M  components of basal lamina and stroma. Therefore, 
we have compared the ability of cultured hum an melanocytes
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F ig u r e  4 -  Immunohistochemical staining of sx. xenograft le­
sions from (a) IF6 with A1.43 anti-ct2 MAbs, (b) 530 with GoH3 
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and human melanoma cell lines, having different metastatic 
capacities in nude mice, to adhere to LM, CO and FN.
No correlation between adhesion to FN  and the metastatic
capacity of the cell lines was found. Since most cells bound well 
to FN, a crucial role for FN in the metastatic process would not 
be expected. This observation confirms and extends the find-
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F ig u r e  5 -  Inhibition of adhesion of human melanoma cell lines BLM and MV3 to LM, COI or COIV. MAbs against a 2 (5E8), 
(GoH3), ß, (4B4) or combinations were added to the cells 30 min before being added to the wells. Data are expressed as percentage of 
remaining adhesion compared to parallel assays without MAbs. SD of triplicate determinations did not exceed 10%. One experiment out 
of 3 is shown. Incubation with W6/32 anti-MHC class-I control MAbs had no effect.
100
80
60
40
20
0
%  adhes ion  to  LM
MCT
NO C H  8A2
1F6 530
ce ll line
M14 Mel57
100
80
60
40
20
%  a d h e s io n  to  C O I
MCT
NO C U  BA2
1F6 530 
c e ll line
M 14 Mel57
F ig u r e  6 -  Stimulation of adhesion of cultured human melanocytes (MCT) and 4 human melanoma cell lines to LM and COI with 
8A2 anti-ßj MAbs. Control adhesion to BSA was less than 5%. SD of triplicate determinations did not exceed 10%. One experiment out 
of 3 is shown.
ings of a nnmber of previous studies in which no positive 
correlation was observed between the capacity of cells to 
adhere to FN and their tumorigenic and/or metastatic behav­
ior (Dedhar and Saulnier, 1990; Terranova et a l , 1984). 
Furthermore, cultured normal human melanocytes have been 
shown to adhere very weakly to LM and CO but strongly to FN 
(Gilchrest et al, 1985; this report).
An important role for LM in the metastatic behavior of 
melanoma cells has been reported (Terranova et a lt 1982, 
1984). Our data confirm these findings and show that (a) highly 
metastatic melanoma cells adhere strongly to LM; (b) this 
adhesion is mediated through VLA-6; and (c) expression of 
the LM receptor VLA-6 a-chain is markedly upregulated in 
highly metastatic human melanoma cells. Furthermore, our 
results indicate that adhesion of human melanoma cells to LM 
is mediated not exclusively through VLA-6 but also through 
VLA-2. Adhesion to COI and COIV has been demonstrated to
be a property of various metastatic melanoma cell lines 
(Kramer and Marks, 1989). Our data  confirm and extend these 
findings: the highly metastatic cells adhere  strongly to COI and 
COIV whereas the non- or poorly metastatic cells and normal 
melanocytes adhere only weakly to these ECM  components. 
Adhesion to both COI and COIV is mediated through VLA-2, 
which is strongly up-regulated in highly metastatic cells, These 
results are in agreement with the findings of Mortarini et a l 
(1991) who reported high a2 and a ß expression on tumor cells 
cultured from human melanoma métastasés but not on tumor 
cells cultured from primary melanomas. Finally, a role for 
VLA-2 in melanoma tum or progression has been suggested by 
Bröcker et a l  (1985) and Klein et a l  (1991), who found that an 
increase in ol2 expression in fresh human melanocytic lesions 
correlated with malignant progression. O ur immunoprécipita­
tion data indicate that elevated expression of a 2 and a 6 in 
highly metastatic cell lines is due not only to increased
320 DANEN ETAL.
cell-surface expression but also to increased biosynthesis. 
Furthermore, from our immunohistochemical data on s.c. 
xenograft lesions, we conclude that the difference in expres­
sion of VLA-2 and VLA -6 between non- and highly metastatic 
cell lines is found not only in vitro but also in vivo.
It is well known that, in order to interact with their ligands, 
pi integrins have to be in an active state (Shimizu et a i , 1990). 
MAbs have been described which induce a high-avidity state of 
these receptors (Van de Wiel-van Kemenade et al, 1992; 
Wayner and Kovach, 1992). Wayner and Kovach (1992) have 
shown that U937 cells, T  and B lymphoblastoid cells and 
PHA-stimulated T-cell blasts require expression of the acti­
vated state of VLA-4 in order to bind the cell adhesion site in 
FN, LDV, whereas A375 melanoma cells do not require such 
activation. These findings suggest that, on certain melanoma 
cells, integrins may be expressed in a constitutively active state. 
Our results extend these findings and show that non- or poorly 
metastatic melanoma cells require induction of a high-avidity 
state of ßi integrins in order to adhere to LM and CO, whereas 
highly metastatic cells do not. Even though only a very low 
amount of VLA-2 and VLA -6 is expressed on the non- or
poorly metastatic cells, once these receptors are activated the 
cells adhere to LM or CO as strongly as do the highly 
metastatic cells. This suggests that the number of receptors is 
less important than the state of activity they are in.
In conclusion, we show that VLA-2 and VLA-6-mediated 
adhesion to LM and CO is strongly increased in highly 
metastatic human melanoma cell lines, and that this adhesion 
can be regulated at the level of (a) a 2ßi and a $ x expression, 
(b) a 2ßi and a 6ßi synthesis, and (c) activation of the a 2ßi and 
oi6px complexes.
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